Thyroid cancer

Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition

Volumn , Issue , 2017, Pages 839-860

  Kitahara, Cari M ^a   Schneider, Arthur B ^b   Brenner, Alina V ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Diagnosis; Environment; Epithelium; Papillary thyroid cancer; Thyroid cancer

Indexed keywords

EID: 85051002298     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/oso/9780190238667.003.0044     Document Type: Chapter

References (227)

1. Ahn HS, Kim HJ, and Welch HG. 2014. Korea's thyroid-cancer "epidemic": screening and overdiagnosis. N Engl J Med, 371(19), 17651767 .PMID: 25372084.
2. Allen NE, Beral V, Casabonne D, et al. 2009. Moderate alcohol intake and cancer incidence in women. J Natl Cancer Inst, 101(5), 296-305 .PMID: 19244173.
3. Almquist M, Johansen D, Bjorge T, et al. 2011. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control, 22(5), 743-751 .PMID: 21380729.
4. Alzahrani AS, Murugan AK, Qasem E, and Al-Hindi HN. 2016. HABP2 gene mutations do not cause familial or sporadic non-medullary thyroid cancer in a highly inbred Middle Eastern population. Thyroid, 26(5), 667-671 .PMID: 26906432.
5. Andersson TM, Johansson AL, Fredriksson I, and Lambe M. 2015. Cancer during pregnancy and the postpartum period: a population-based study. Cancer, 121(12), 2072-2077 .PMID: 25737403.
6. Arnold M, Pandeya N, Byrnes G, et al. 2015. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol, 16(1), 36-46 .PMCID: PMC4314462.
7. Aschebrook-Kilfoy B, DellaValle CT, Purdue M, et al. 2015. Polybrominated diphenyl ethers and thyroid cancer risk in the Prostate, Colorectal, Lung, and Ovarian Cancer Screening Trial cohort. Am J Epidemiol, 181(11), 883-888 .PMCID: PMC4445391.
8. Aschebrook-Kilfoy B, Grogan RH, Ward MH, Kaplan E, and Devesa SS. 2013a. Follicular thyroid cancer incidence patterns in the United States, 1980-2009. Thyroid, 23(8), 1015-1021 .PMCID: PMC3752506.
9. Aschebrook-Kilfoy B, Shu XO, Gao YT, et al. 2013b. Thyroid cancer risk and dietary nitrate and nitrite intake in the Shanghai women's health study. Int J Cancer, 132(4), 897-904 .PMCID: PMC3443521.
10. Aschebrook-Kilfoy B, Ward MH, Della Valle CT, and Friesen MC. 2014. Occupation and thyroid cancer. Occup Environ Med, 71(5), 366-380 .PMCID: PMC4059396.
11. Astakhova LN, Anspaugh LR, Beebe GW, et al. 1998. Chernobyl-related thyroid cancer in children of Belarus: a case-control study. Radiat Res, 150(3), 349-356 .PMID: 9728663.
12. Balasubramaniam S, Ron E, Gridley G, Schneider AB, and Brenner AV. 2012. Association between benign thyroid and endocrine disorders and subsequent risk of thyroid cancer among 4.5 million U.S. male veterans. J Clin Endocrinol Metab, 97(8), 2661-2669 .PMCID: PMC3410263.
13. Baloch Z, LiVolsi VA, and Tondon R. 2013. Aggressive variants of follicular cell derived thyroid carcinoma; the so called "real thyroid carcinomas." J Clin Pathol, 66(9), 733-743 .PMID: 23626010.
14. Becker C, Jick SS, Meier CR, and Bodmer M. 2015. No evidence for a decreased risk of thyroid cancer in association with use of metformin or other antidiabetic drugs: a case-control study. BMC Cancer, 15, 719 .PMCID: PMC4609106.
15. Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. 2013. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun, 42, 130-135 .PMCID: PMC3646904.
16. Boelaert K, Horacek J, Holder RL, et al. 2006. Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab, 91(11), 4295-4301 .PMID: 16868053.
17. Bosetti C, Kolonel L, Negri E, et al. 2001. A pooled analysis of case-control studies of thyroid cancer. VI. Fish and shellfish consumption. Cancer Causes Control, 12(4), 375-382 .PMID: 11456234.
18. Bouville A, Beck HL, and Simon SL. 2010. Doses from external irradiation to Marshall Islanders from Bikini and Enewetak nuclear weapons tests. Health Phys, 99(2), 143-156 .PMID: 20622549.
19. Braganza MZ, de Gonzalez AB, Schonfeld SJ, et al. 2014. Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer. Cancer Prev Res (Phila), 7(4), 418-25 .PMCID: PMC3976437.
20. Braganza MZ, Potischman N, Park Y, et al. 2015. Adolescent and mid-life diet and subsequent risk of thyroid cancer in the NIH-AARP diet and health study. Int J Cancer, 137(10), 2413-2423 .PMID: 25974060.
21. Brenner AV, Tronko MD, Hatch M, et al. 2011. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect, 119(7), 933-939 .PMCID: PMC3222994.
22. Brinton LA, Moghissi KS, Scoccia B, et al. 2015. Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertil Steril, 104(4), 980-988 .PMCID: PMC4592810.
23. Burgess JR, Dwyer T, McArdle K, Tucker P, and Shugg D. 2000. The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab, 85(4), 1513-1517 .PMID: 10770190.
24. Cancer Genome Atlas Research Network. 2014. Integrated genomic characterization of papillary thyroid carcinoma. Cell, 159(3), 676-690 .PMCID: PMC4243044.
25. Cappola AR, and Mandel SJ. 2015. Improving the long-term management of benign thyroid nodules. JAMA, 313(9), 903-904 .PMID: 25734731.
26. Cardis E, Kesminiene A, Ivanov V, et al. 2005. Risk of thyroid cancer after exposure to 131I in childhood. J Natl Cancer Inst, 97(10), 724-732 .PMID: 15900042.
27. Carling T, Ocal IT, and Udelsman R. 2007. Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer? World J Surg, 31(5), 916-923 .PMID: 17345120.
28. Choi JS, Kim EK, Moon HJ, and Kwak JY. 2015. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine, 48(1), 264-271 .PMID: 24858734.
29. Chowdhury R, Sinha B, Sankar MJ, et al. 2015. Breastfeeding and maternal health outcomes: a systematic review and meta-analysis. Acta Paediatr, 104(467), 96-113 .PMCID: PMC4670483.
30. Cipriani NA, Nagar S, Kaplan SP, et al. 2015. Follicular thyroid carcinoma: how have histologic diagnoses changed in the last half-century and what are the prognostic implications? Thyroid, 25(11), 1209-1216 .PMID: 26440366.
31. Clero E, Doyon F, Chungue V, et al. 2012. Dietary iodine and thyroid cancer risk in French Polynesia: a case-control study. Thyroid, 22(4), 422-429 .PMID: 22280227.
32. Cornett WR, Sharma AK, Day TA, et al. 2007. Anaplastic thyroid carcinoma: an overview. Curr Oncol Rep, 9(2), 152-158 .PMID: 17288883.
33. Crump C, Sundquist J, Sieh W, Winkleby MA, and Sundquist K. 2015. Fetal growth and subsequent maternal risk of thyroid cancer. Int J Cancer, 138(5), 1085-1093 .PMID: 26379007.
34. Czene K, Lichtenstein P, and Hemminki K. 2002. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family- Cancer Database. Int J Cancer, 99(2), 260-266 .PMID: 11979442.
35. Dabrowska AM, Tarach JS, Kurowska M, and Nowakowski A. 2014. Thyroid diseases in patients with acromegaly. Arch Med Sci, 10(4), 837-845 .PMCID: PMC4175760.
36. Dal Maso L, Bosetti C, La Vecchia C, and Franceschi S. 2009. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control, 20(1), 75-86 .PMID: 18766448.
37. Davies L, and Welch HG. 2006. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA, 295(18), 2164-2167 .PMID: 16684987.
38. Davis S, Kopecky KJ, Hamilton TE, Onstad L, and Hanford Thyroid Disease Study Team. 2004a. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site. JAMA, 292(21), 2600-2613 .PMID: 15572718.
39. Davis S, Stepanenko V, Rivkind N, et al. 2004b. Risk of thyroid cancer in the Bryansk Oblast of the Russian Federation after the Chernobyl Power Station accident. Radiat Res, 162(3), 241-248 .PMID: 15332999.
40. Demers LM. 2004. Thyroid disease: pathophysiology and diagnosis. Clin Lab Med, 24(1), 19-28 .PMID: 15157555.
41. Dickman PW, Holm LE, Lundell G, Boice JD, Jr., and Hall P. 2003. Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden. Int J Cancer, 106(4), 580-587 .PMID: 12845656.
42. Doniach I. 1957. Comparison of the carcinogenic effect of x-irradiation with radioactive iodine on the rat's thyroid. Br J Cancer, 11(1), 67-76 .PMCID: PMC2073934.
43. Duffy BJ, Jr., and Fitzgerald PJ. 1950. Cancer of the thyroid in children: a report of 28 cases. J Clin Endocrinol Metab, 10(10), 1296-1308 .PMID: 14794754.
44. Duntas LH. 2006. The role of selenium in thyroid autoimmunity and cancer. Thyroid, 16(5), 455-460 .PMID: 16756467.
45. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. 2010. AJCC cancer staging manual (7th ed). New York: Springer.
46. Enewold L, Zhu K, Ron E, et al. 2009. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev, 18(3), 784-791 .PMCID: PMC2676561.
47. Engels EA, Pfeiffer RM, Fraumeni JF, Jr., et al. 2011. Spectrum of cancer risk among US solid organ transplant recipients. JAMA, 306(17), 1891-1901 .PMCID: PMC3310893.
48. Fallah M, Pukkala E, Tryggvadottir L, et al. 2013. Risk of thyroid cancer in first-degree relatives of patients with non-medullary thyroid cancer by histology type and age at diagnosis: a joint study from five Nordic countries. J Med Genet, 50(6), 373-382 .PMID: 23585692.
49. Feldt-Rasmussen U, and Rasmussen AK. 2010. Autoimmunity in differentiated thyroid cancer: significance and related clinical problems. Hormones (Athens), 9(2), 109-117 .PMID: 20687394.
50. Ferlay J, Soerjomataram I, Dikshit R, et al. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136(5), E359-386 .PMID: 25220842.
51. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2013. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Available from: http://globocan.iarc.fr.Accessed on October 16, 2015.
52. Figlioli G, Landi S, Romei C, Elisei R, and Gemignani F. 2013. Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form. Mutat Res, 752(1), 36-44 .PMID: 23059849.
53. Flegal KM, Carroll MD, Ogden CL, and Curtin LR. 2010. Prevalence and trends in obesity among US adults, 1999-2008. JAMA, 303(3), 235-241 .PMID: 20071471.
54. Forman D BF, Brewster DH, Gombe Mbalawa C, Kohler B, Pineros M, Steliarova-Foucher E, Swaminathan R, Ferlay J. 2014. Cancer incidence in five continents, IARC (ed.), (Vol. X). Lyon, France.
55. Franceschi S, Preston-Martin S, Dal Maso L, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control, 10(6), 583-595 .PMID: 10616827.
56. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J, and Boyle P. 1999. Cancer incidence and mortality after radioiodine treatment for hyperthy-roidism: a population-based cohort study. Lancet, 353(9170), 2111-2115 .PMID: 10382695.
57. From G, Mellemgaard A, Knudsen N, Jorgensen T, and Perrild H. 2000. Review of thyroid cancer cases among patients with previous benign thyroid dis-orders. Thyroid, 10(8), 697-700 .PMID: 11014315.
58. Furukawa K, Preston D, Funamoto S, et al. 2013. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer, 132(5), 1222-1226 .PMCID: PMC3910094.
59. Ganly I, Ricarte Filho J, Eng S, et al. 2013. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J Clin Endocrinol Metab, 98(5), E962-972 .PMID: 23543667.
60. Gara SK, Jia L, Merino MJ, et al. 2015. Germline HABP2 mutation causing familial nonmedullary thyroid cancer. N Engl J Med, 373(5), 448-455 .PMCID: PMC4562406.
61. Goske MJ, Frush DP, Brink JA, et al. 2014. Curbing potential radiation-induced cancer risks in oncologic imaging: perspectives from the "image gently" and "image wisely" campaigns. Oncology (Williston Park), 28(3), 232-238, 243 .PMID: 24855732.
62. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. 2009. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet, 41(4), 460-464 .PMCID: PMC3664837.
63. Gudmundsson J, Sulem P, Gudbjartsson DF, et al. 2012. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat Genet, 44(3), 319-322 .PMCID: PMC3655412.
64. Hahn K, Schnell-Inderst P, Grosche B, and Holm LE. 2001. Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat Res, 156(1), 61-70 .PMID: 11418074.
65. Hannibal CG, Jensen A, Sharif H, and Kjaer SK. 2008. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod, 23(2), 451-456 .PMID: 18065402.
66. Harach HR, Escalante DA, and Day ES. 2002. Thyroid cancer and thyroiditis in Salta, Argentina: a 40-yr study in relation to iodine prophylaxis. Endocr Pathol, 13(3), 175-181 .PMID: 12446916.
67. Harari A, Li N, and Yeh MW. 2014. Racial and socioeconomic disparities in presentation and outcomes of well-differentiated thyroid cancer. J Clin Endocrinol Metab, 99(1), 133-141 .PMCID: PMC3879674.
68. Harding JL, Shaw JE, Peeters A, Cartensen B, and Magliano DJ. 2015. Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation. Diabetes Care, 38(2), 264-270 .PMID: 25488912.
69. Haselkorn T, Stewart SL, and Horn-Ross PL. 2003. Why are thyroid cancer rates so high in southeast asian women living in the United States? The Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev, 12(2), 144-150 .PMID: 12582024.
70. Hashibe M, Galeone C, Buys SS, et al. 2015. Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. Br J Cancer, 113(5), 809-816 .PMID: 26291054.
71. Hatch M, Brenner A, Bogdanova T, et al. 2009. A screening study of thyroid cancer and other thyroid diseases among individuals exposed in utero to iodine-131 from Chernobyl fallout. J Clin Endocrinol Metab, 94(3), 899-906 .PMCID: PMC2681280.
72. Hedinger C, Williams ED, Sobin LH. 1988. Histological typing of thyroid tumors (2nd ed.). Berlin; Heidelberg; New York: Springer.
73. Hedinger C, Williams ED, and Sobin LH. 1989. The WHO histological clas-sification of thyroid tumors: a commentary on the second edition. Cancer, 63(5), 908-911 .PMID: 2914297.
74. Hemminki K, Forsti A, Fallah M, et al. 2014. Risk of cancer in patients with medically diagnosed hay fever or allergic rhinitis. Int J Cancer, 135(10), 2397-2403 .PMID: 24692097.
75. Hempelmann LH. 1968. Risk of thyroid neoplasms after irradiation in childhood. Studies of populations exposed to radiation in childhood show a dose response over a wide dose range. Science, 160(3824), 159-163 .PMID: 5642565.
76. Hieu TT, Russell AW, Cuneo R, et al. 2012. Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis. Endocr Relat Cancer, 19(5), 645-655 .PMID: 22851687.
77. Hoffman DA, McConahey WM, Fraumeni JF, Jr., and Kurland LT. 1982. Cancer incidence following treatment of hyperthyroidism. Int J Epidemiol, 11(3), 218-224 .PMID: 7129736.
78. Hognas E, Kauppila A, Pukkala E, and Tapanainen JS. 2014. Cancer risk in women with 10 or more deliveries. Obstet Gynecol, 123(4), 811-816 .PMID: 24785609.
79. Holm LE, Hall P, Wiklund K, et al. 1991. Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst, 83(15), 1072-1077 .PMID: 1875414.
80. Horn-Ross PL, Canchola AJ, Ma H, Reynolds P, and Bernstein L. 2011. Hormonal factors and the risk of papillary thyroid cancer in the California Teachers Study cohort. Cancer Epidemiol Biomarkers Prev, 20(8), 1751-1759 .PMCID: PMC3288117.
81. Horn-Ross PL, Morris JS, Lee M, et al. 2001. Iodine and thyroid cancer risk among women in a multiethnic population: the Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev, 10(9), 979-985 .PMID: 11535551.
82. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, and Cronin KA. 2015. SEER cancer statistics 2012. Available from: http://seer.cancer.gov/csr/1975_2012/.Accessed on December 1, 2015.
83. Hsu CH, Huang CL, Hsu YH, et al. 2014. Co-occurrence of second primary malignancy in patients with thyroid cancer. QJM, 107(8), 643-648 .PMID: 24623860.
84. Hung MH, Liu CJ, Teng CJ, et al. 2016. Risk of second non-breast primary cancer in male and female breast cancer patients: a population-based cohort study. PLoS One, 11(2), e0148597 .PMCID: PMC4760946.
85. Hung SH, Lin HC, and Chung SD. 2015. Statin use and thyroid cancer: a population-based case-control study. Clin Endocrinol (Oxf), 83(1), 111-116 .PMID: 25074346.
86. Hwang CY, Chen YJ, Lin MW, et al. 2012. Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. Int J Cancer, 130(5), 1160-1167 .PMID: 21455988.
87. Iribarren C, Haselkorn T, Tekawa IS, and Friedman GD. 2001. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer, 93(5), 745-750 .PMID: 11477590.
88. Ito Y, and Miyauchi A. 2015. Nonoperative management of low-risk differentiated thyroid carcinoma. Curr Opin Oncol, 27(1), 15-20 .PMID: 25340592.
89. Ito Y, Nikiforov YE, Schlumberger M, and Vigneri R. 2013. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol, 9(3), 178-184 .PMID: 23358352.
90. Ivanov VK, Kashcheev VV, Chekin SY, et al. 2012. Radiation-epidemiological studies of thyroid cancer incidence in Russia after the Chernobyl accident (estimation of radiation risks, 1991-2008 follow-up period). Radiat Prot Dosimetry, 151(3), 489-499 .PMID: 22416255.
91. Jankovic B, Le KT, and Hershman JM. 2013. Clinical Review: Hashimoto's thyroiditis and papillary thyroid carcinoma: is there a correlation? J Clin Endocrinol Metab, 98(2), 474-482 .PMID: 23293329.
92. Ji J, Shu X, Li X, et al. 2009. Cancer risk in hospitalised asthma patients. Br J Cancer, 100(5), 829-833 .PMCID: PMC2653753.
93. Jing Z, Hou X, Liu Y, et al. 2015. Association between height and thyroid cancer risk: a meta-analysis of prospective cohort studies. Int J Cancer, 137(6), 1484-1490 .PMID: 25693727.
94. Jorgensen KT, Nielsen NM, Pedersen BV, Jacobsen S, and Frisch M. 2012. Hyperemesis, gestational hypertensive disorders, pregnancy losses and risk of autoimmune diseases in a Danish population-based cohort. J Autoimmun, 38(2-3), J120-128 .PMID: 22226784.
95. Jorgensen TJ. 2016. Re: Thyroid cancer among young people in Fukushima. Epidemiology, 27(3), e17 .PMID: 26841060.
96. Kabat GC, Kim MY, Thomson CA, et al. 2012a. Anthropometric factors and physical activity and risk of thyroid cancer in postmenopausal women. Cancer Causes Control, 23(3), 421-30 .PMID: 22212611.
97. Kabat GC, Kim MY, Wactawski-Wende J, et al. 2012b. Menstrual and repro-ductive factors, exogenous hormone use, and risk of thyroid carcinoma in postmenopausal women. Cancer Causes Control, 23(12), 2031-2040 .PMID: 23090034.
98. Kabat GC, Kim MY, Wactawski-Wende J, and Rohan TE. 2012c. Smoking and alcohol consumption in relation to risk of thyroid cancer in postmenopausal women. Cancer Epidemiol, 36(4), 335-340 .PMID: 22525339.
99. Karamchandani D, Arias-Amaya R, Donaldson N, Gilbert J, and Schulte KM. 2010. Thyroid cancer and renal transplantation: a meta-analysis. Endocr Relat Cancer, 17(1), 159-167 .PMID: 19942714.
100. Kesminiene A, Evrard AS, Ivanov VK, et al. 2012. Risk of thyroid cancer among chernobyl liquidators. Radiat Res, 178(5), 425-436 .PMID: 22998226.
101. Kilfoy BA, Zhang Y, Park Y, et al. 2011. Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP Diet and Health Study. Int J Cancer, 129(1), 160-172 .PMCID: PMC3016446.
102. Kilfoy BA, Zheng T, Holford TR, et al. 2009. International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control, 20(5), 525-531 .PMCID: PMC2788231.
103. Kim HJ, Kim NK, Choi JH, et al. 2013. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf), 78(1), 134-140 .PMID: 22812676.
104. Kitahara CM, Gamborg M, Berrington de Gonzalez A, Sorensen TI, and Baker JL. 2014. Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res, 74(1), 235-242 .PMCID: PMC3891884.
105. Kitahara CM, Linet MS, Beane Freeman LE, et al. 2012a. Cigarette smoking, alcohol intake, and thyroid cancer risk: a pooled analysis of five prospective studies in the United States. Cancer Causes Control, 23(10), 1615-1624 .PMCID: PMC3511822.
106. Kitahara CM, McCullough M, Franceschi S, et al. 2016. Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies. Thyroid, 26(2), 306-318 .PMID: 26756356.
107. Kitahara CM, Platz EA, Beane Freeman LE et al. 2012b. Physical activity, dia-betes, and thyroid cancer risk: a pooled analysis of five prospective studies. Cancer Causes Control [Epub ahead of print] .PMCID: PMC3586378.
108. Knudsen N, Bulow I, Laurberg P, et al. 2001. Alcohol consumption is associated with reduced prevalence of goitre and solitary thyroid nodules. Clin Endocrinol (Oxf), 55(1), 41-46 .PMID: 11453951.
109. Kohler BA, Sherman RL, Howlader N, et al. 2015. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J Natl Cancer Inst, 107(6), djv048 .PMID: 25825511.
110. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, and Hinds MW. 1990. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control, 1(3), 223-234 .PMID: 2102295.
111. Kopp P, Kimura ET, Aeschimann S, et al. 1994. Polyclonal and monoclonal thyroid nodules coexist within human multinodular goiters. J Clin Endocrinol Metab, 79(1), 134-139 .PMID: 7517946.
112. Kwon H, Kim M, Choi YM, et al. 2015. Lack of associations between body mass index and clinical outcomes in patients with papillary thyroid carcinoma. Endocrinol Metab (Seoul), 30(3), 305-311 .PMCID: PMC4595355.
113. La Vecchia C, Malvezzi M, Bosetti C, et al. 2015. Thyroid cancer mortality and incidence: a global overview. Int J Cancer, 136(9), 2187-2195 .PMID: 25284703.
114. Landa I, and Robledo M. 2011. Association studies in thyroid cancer suscep-tibility: are we on the right track? J Mol Endocrinol, 47(1), R43-58 .PMID: 21830323.
115. Law CS, Douglass JM, Farman AG, et al. 2014. The image gently in dentistry campaign: partnering with parents to promote the responsible use of x-rays in pediatric dentistry. Pediatr Dent, 36(7), 458-459 .PMID: 25514072.
116. Lerro CC, Koutros S, Andreotti G, et al. 2015. Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study. Occup Environ Med, 72(10), 736-744 .PMID: 26150671.
117. Liang Y, Yang Z, Qin B, and Zhong R. 2014. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis, 73(6), 1151-1156 .PMID: 23687261.
118. Lin SW, Wheeler DC, Park Y, et al. 2012. Prospective study of ultraviolet radia-tion exposure and risk of cancer in the United States. Int J Cancer, 131(6), E1015-1023 .PMCID: PMC3402606.
119. Lind P, Kumnig G, Heinisch M, et al. 2002. Iodine supplementation in Austria: methods and results. Thyroid, 12(10), 903-907 .PMID: 12487773.
120. Lindsay S, Potter GD, and Chaikoff IL. 1957. Thyroid neoplasms in the rat: a comparison of naturally occurring and I131-induced tumors. Cancer Res, 17(3), 183-189 .PMID: 13413859.
121. Liu X, Qu S, Liu R, et al. 2014. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological charac-teristics of thyroid cancer. J Clin Endocrinol Metab, 99(6), E1130-1136 .PMID: 24617711.
122. Liu Z, Maimaiti Y, Yu P, et al. 2015. Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma. Int J Clin Exp Med, 8(9), 16472-16479 .PMCID: PMC4659061.
123. LiVolsi VA, Abrosimov AA, Bogdanova T, et al. 2011. The Chernobyl thyroid cancer experience: pathology. Clin Oncol (R Coll Radiol), 23(4), 261 PMID: 21333507.
124. LiVolsi VA, and Asa SL. 1994. The demise of follicular carcinoma of the thyroid gland. Thyroid, 4(2), 233-236 .PMID: 7920009.
125. Lope V, Perez-Gomez B, Aragones N, et al. 2006. Occupational exposure to ionizing radiation and electromagnetic fields in relation to the risk of thyroid cancer in Sweden. Scand J Work Environ Health, 32(4), 276-284 .PMID: 16932825.
126. Lu CH, Lee KD, Chen PT, et al. 2013. Second primary malignancies following thyroid cancer: a population-based study in Taiwan. Eur J Endocrinol, 169(5), 577-585 .PMID: 23939917.
127. Lyon JL, Alder SC, Stone MB, et al. 2006. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data. Epidemiology, 17(6), 604-614 .PMID: 17028502.
128. Mack WJ, Preston-Martin S, Dal Maso L, et al. 2003. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control, 14(8), 773-785 .PMID: 14674742.
129. Mancikova V, Cruz R, Inglada-Perez L, et al. 2015. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations. Int J Cancer, 137(8), 1870-1878 .PMID: 25855579.
130. Mao S, Shen H, and Zhang J. 2016. Systemic lupus erythematosus and malignan-cies risk. J Cancer Res Clin Oncol, 142(1), 253-262 .PMID: 26319223.
131. McFadden DG, Dias-Santagata D, Sadow PM, et al. 2014. Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab, 99(11), E2457-2462 .PMCID: PMC4223441.
132. Meinhold CL, Ron E, Schonfeld SJ, et al. 2010. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol, 171(2), 242-252 .PMCID: PMC3290908.
133. Mellemgaard A, From G, Jorgensen T, et al. 1998. Cancer risk in individuals with benign thyroid disorders. Thyroid, 8(9), 751-754 .PMID: 9777744.
134. Mete O, and Asa SL. 2013. Precursor lesions of endocrine system neoplasms. Pathology, 45(3), 316-330 .PMID: 23478233.
135. Minamimoto R, Senda M, Jinnouchi S, et al. 2014. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey. Anticancer Res, 34(8), 4439-4445 .PMID: 25075083.
136. Mortensen JD, Woolner LB, and Bennett WA. 1955. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab, 15(10), 1270-1280 .PMID: 13263417.
137. Mosconi G, Stalteri L, Centofanti F, et al. 2011. Incidence of cancer in kidney transplantation waiting list patients: a single center experience. Transplant Proc, 43(4), 1003-1005 .PMID: 21620036.
138. Moses W, Weng J, and Kebebew E. 2011. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmed- ullary thyroid cancer. Thyroid, 21(4), 367-371 .PMCID: PMC3070337.
139. Muirhead CR, O'Hagan JA, Haylock RG, et al. 2009. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br J Cancer, 100(1), 206-212 .PMCID: PMC2634664.
140. Navarro Silvera SA, Miller AB, and Rohan TE. 2005. Risk factors for thyroid cancer: a prospective cohort study. Int J Cancer, 116(3), 433-438 .PMID: 15818623.
141. Negri E, Ron E, Franceschi S, et al. 1999. A pooled analysis of case-control studies of thyroid cancer. I. Methods. Cancer Causes Control, 10(2), 131-142 .PMID: 10231162.
142. Nielsen SM, White MG, Hong S, et al. 2016. The breast-thyroid cancer link: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 25(2), 231-238 .PMCID: PMC4770576.
143. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H, and Fagin JA. 1997. Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Res, 57(9), 1690-1694 .PMID: 9135009.
144. Nikiforov YE, Seethala RR, Tallini G, et al. 2016. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol, 2(8), 1023-1029, PMID: 27078145.
145. Nikiforova MN, Lynch RA, Biddinger PW, et al. 2003. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab, 88(5), 2318-2326 .PMID: 12727991.
146. Nose V. 2011. Familial thyroid cancer: a review. Mod Pathol, 24 Suppl 2, S19-33 .PMID: 21455198.
147. O'Grady TJ, Kitahara CM, DiRienzo AG, and Gates MA. 2014. The association between selenium and other micronutrients and thyroid cancer incidence in the NIH-AARP Diet and Health Study. PLoS One, 9(10), e110886 .PMCID: PMC4203851.
148. Oh CM, Jung KW, Won YJ et al. 2015. Age-period-cohort analysis of thyroid cancer incidence in Korea. Cancer Res Treat, 47(3), 362-369 .PMCID: PMC4506117.
149. Ostroumova E, Gudzenko N, Brenner A, et al. 2014. Thyroid cancer incidence in Chornobyl liquidators in Ukraine: SIR analysis, 1986-2010. Eur J Epidemiol, 29(5), 337-342 .PMID: 24705729.
150. Pacini F, Castagna MG, Cipri C, and Schlumberger M. 2010. Medullary thyroid carcinoma. Clin Oncol (R Coll Radiol), 22(6), 475-485 .PMID: 20627492.
151. Patel D, Kitahara CM, Park Y, et al. 2015. Thyroid cancer and nonsteroidal anti-inflammatory drug use: a pooled analysis of patients older than 40 years of age. Thyroid, 25(12), 1355-1362 .PMCID: PMC4684667.
152. Pazaitou-Panayiotou K, Polyzos SA, and Mantzoros CS. 2013. Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms. Obes Rev, 14(12), 1006-1022 .PMID: 24034423.
153. Pellegriti G, De Vathaire F, Scollo C, et al. 2009. Papillary thyroid cancer inci-dence in the volcanic area of Sicily. J Natl Cancer Inst, 101(22), 1575-1583 .PMID: 19893009.
154. Pereira JS, da Silva JG, Tomaz RA, et al. 2015. Identification of a novel germ- line FOXE1 variant in patients with familial non-medullary thyroid carci-noma (FNMTC). Endocrine, 49(1), 204-214 .PMID: 25381600.
155. Pollak MN, Schernhammer ES, and Hankinson SE. 2004. Insulin-like growth factors and neoplasia. Nat Rev Cancer, 4(7), 505-518 .PMID: 15229476.
156. Preston-Martin S, Franceschi S, Ron E, and Negri E. 2003. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control, 14(8), 787-789 .PMID: 14674743.
157. Rahu M, Rahu K, Auvinen A, et al. 2006. Cancer risk among Chernobyl cleanup workers in Estonia and Latvia, 1986-1998. Int J Cancer, 119(1), 162-168 .PMID: 16432838.
158. Ren Y, Kitahara CM, Berrington de Gonzalez A, et al. 2014. Lack of association between fingernail selenium and thyroid cancer risk: a case-control study in French Polynesia. Asian Pac J Cancer Prev, 15(13), 5187-5194 .PMID: 25040973.
159. Renehan AG, Tyson M, Egger M, Heller RF, and Zwahlen M. 2008. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet, 371(9612), 569-578 .PMID: 18280327.
160. Rinaldi S, Lise M, Clavel-Chapelon F, et al. 2012. Body size and risk of differ-entiated thyroid carcinomas: findings from the EPIC study. Int J Cancer, 131(6), E1004-1014 .PMID: 22511178.
161. Rinaldi S, Plummer M, Biessy C, et al. 2014. Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. J Natl Cancer Inst, 106(6), dju097 .PMID: 24824312.
162. Ron E, Doody MM, Becker DV, et al. 1998. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA, 280(4), 347-355 .PMID: 9686552.
163. Ron E, Lubin JH, Shore RE, et al. 1995. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res, 141(3), 259-277 .PMID: 7871153.
164. Ron E, Schneider AB. 2006. Thyroid cancer. In: Schottenfeld D, Fraumeni JF, Jr. (eds.), Cancer epidemiology and prevention (3rd ed.). New York: Oxford University Press.
165. Ronckers CM, McCarron P, and Ron E. 2005. Thyroid cancer and multiple primary tumors in the SEER cancer registries. Int J Cancer, 117(2), 281-288 .PMID: 15880372.
166. Rowland KJ, and Moley JF. 2015. Hereditary thyroid cancer syndromes and genetic testing. J Surg Oncol, 111(1), 51-60 .PMID: 25351655.
167. Ryodi E, Metso S, Jaatinen P, et al. 2015. Cancer incidence and mortality in patients treated either with RAI or thyroidectomy for hyperthyroidism. J Clin Endocrinol Metab, 100(10), 3710-3717 .PMID: 26262435.
168. Schmid D, Ricci C, Behrens G, and Leitzmann MF. 2015. Adiposity and risk of thyroid cancer: a systematic review and meta-analysis. Obes Rev, 16(12), 1042-1054 .PMID: 26365757.
169. Schmidt JA, Allen NE, Almquist M, et al. 2014. Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev, 23(6), 976-985 .PMCID: PMC4046912.
170. Schonfeld SJ, Lee C, and Berrington de Gonzalez A. 2011a. Medical exposure to radiation and thyroid cancer. Clin Oncol (R Coll Radiol), 23(4), 244-250 .PMID: 21296564.
171. Schonfeld SJ, Ron E, Kitahara CM, et al. 2011b. Hormonal and reproductive factors and risk of postmenopausal thyroid cancer in the NIH- AARP Diet and Health Study. Cancer Epidemiol, 35(6), e85-90 .PMCID: PMC3215902.
172. SEER. 2012. ICD-O-3 SEER site/histology validation list. Available from: http://seer.cancer.gov/icd-o-3/sitetype.icdo3.d20121205.pdf. Accessed on May 1, 2016.
173. Sen A, Tsilidis KK, Allen NE, et al. 2015. Baseline and lifetime alcohol con-sumption and risk of differentiated thyroid carcinoma in the EPIC study. Br J Cancer, 113(5), 840-847 .PMID: 26313664.
174. Shakhtarin VV, Tsyb AF, Stepanenko VF, et al. 2003. Iodine deficiency, radiation dose, and the risk of thyroid cancer among children and adolescents in the Bryansk region of Russia following the Chernobyl power station accident. Int J Epidemiol, 32(4), 584-591 .PMID: 12913034.
175. Silberstein EB, Alavi A, Balon HR, et al. 2012. The SNMMI practice guideline for therapy of thyroid disease with 131I 3.0. J Nucl Med, 53(10), 1633-1651 .PMID: 22787108.
176. Simon SL, Bouville A, Land CE, and Beck HL. 2010. Radiation doses and cancer risks in the Marshall Islands associated with exposure to radioactive fallout from Bikini and Enewetak nuclear weapons tests: summary. Health Phys, 99(2), 105-123 .PMCID: PMC4042840.
177. Sont WN, Zielinski JM, Ashmore JP, et al. 2001. First analysis of cancer inci-dence and occupational radiation exposure based on the National Dose Registry of Canada. Am J Epidemiol, 153(4), 309-318 .PMID: 11207146.
178. Spampinato MV, Tipnis S, Tavernier J, and Huda W. 2015. Thyroid doses and risk to paediatric patients undergoing neck CT examinations. Eur Radiol, 25(7), 1883-1890 .PMID: 25638220.
179. Stezhko VA, Buglova EE, Danilova LI, et al. 2004. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: objectives, design and methods. Radiat Res, 161(4), 481-492 .PMID: 15038762.
180. Subramanian S, Goldstein DP, Parlea L, et al. 2007. Second primary malignancy risk in thyroid cancer survivors: a systematic review and metaanalysis. Thyroid, 17(12), 1277-1288 .PMID: 18020916.
181. Sugishita Y, Kammori M, Yamada O, et al. 2014. Biological differential diag-nosis of follicular thyroid tumor and Hurthle cell tumor on the basis of telomere length and hTERT expression. Ann Surg Oncol, 21(7), 2318-2325 .PMID: 24562933.
182. Suzuki S. 2016a. Childhood and adolescent thyroid cancer in Fukushima after the Fukushima Daiichi nuclear power plant accident: 5 years on. Clin Oncol (R Coll Radiol), 28(4), 263-271 .PMID: 26822892.
183. Suzuki S. 2016b. Re: Thyroid cancer among young people in Fukushima. Epidemiology, 27(3), e19 .PMID: 26849640.
184. Tajtakova M, Semanova Z, Tomkova Z, et al. 2006. Increased thyroid volume and frequency of thyroid disorders signs in schoolchildren from nitrate polluted area. Chemosphere, 62(4), 559-564 .PMID: 16095667.
185. Takahashi T, Schoemaker MJ, Trott KR, et al. 2003. The relationship of thyroid cancer with radiation exposure from nuclear weapon testing in the Marshall Islands. J Epidemiol, 13(2), 99-107 .PMID: 12675119.
186. Thoresen SO, Myking O, Glattre E, et al. 1988. Serum thyroglobulin as a preclinical tumour marker in subgroups of thyroid cancer. Br J Cancer, 57(1), 105-108 .PMCID: PMC2246681.
187. Tomsic J, Fultz R, Liyanarachchi S, et al. 2016. HABP2 G534E variant in papillary thyroid carcinoma. PLoS One, 11(1), e0146315 .PMCID: PMC4706330.
188. Tonacchera M, Pinchera A, Dimida A, et al. 2004. Relative potencies and additivity of perchlorate, thiocyanate, nitrate, and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid, 14(12), 1012-1019 .PMID: 15650353.
189. Tresallet C, Seman M, Tissier F, et al. 2014. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery, 156(5), 1145-1152 .PMID: 24878452.
190. Tronko MD, Howe GR, Bogdanova TI, et al. 2006. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J Natl Cancer Inst, 98(13), 897-903 .PMID: 16818853.
191. Truong T, Baron-Dubourdieu D, Rougier Y, and Guenel P. 2010. Role of dietary iodine and cruciferous vegetables in thyroid cancer: a countrywide case- control study in New Caledonia. Cancer Causes Control, 21(8), 1183-1192 .PMCID: PMC3496161.
192. Tseng CH. 2012. Thyroid cancer risk is not increased in diabetic patients. PLoS One, 7(12), e53096 .PMCID: PMC3531389.
193. Tseng CH. 2014. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. PLoS One, 9(10), e109852 .PMCID: PMC4193839.
194. Tsuda T, Tokinobu A, Yamamoto E, and Suzuki E. 2015. Thyroid cancer detection by ultrasound among residents ages 18 years and younger in Fukushima, Japan: 2011 to 2014. Epidemiology, 27(3), 316-322 .PMID: 26441345.
195. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, and Tryggvadottir L. 1997. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev, 6(11), 863-873 .PMID: 9367058.
196. UNSCEAR. 2006. UNSCEAR: effects of ionizing radiation (Vol. I). New York: United Nations.
197. UNSCEAR. 2008. United Nations Scientific Committee on the Effects of Atomic Radiation: Sources and effects of ionizing radiation (Vol. II). New York: United Nations.
198. UNSCEAR. 2013. Sources, effects and risks of ionizing radiation. New York: United Nations.
199. US Food and Drug Administration. 2001. Guidance: Potassium iodide as a thyroid blocking agent in radiation emergencies. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
200. Vandraas KF, Grjibovski AM, Stoer NC, et al. 2015a. Hyperemesis gravidarum and maternal cancer risk: a scandinavian nested case-control study. Int J Cancer, 137(5), 1209-1216 .PMID: 25665163.
201. Vandraas KF, Vikanes AV, Stoer NC, et al. 2015b. Hyperemesis gravidarum and risk of cancer in offspring: a Scandinavian registry-based nested case- control study. BMC Cancer, 15, 398 .PMCID: PMC4430929.
202. Veiga LH, Holmberg E, Anderson H, et al. 2016. Thyroid cancer after childhood exposure to external radiation: an updated pooled analysis of 12 studies. Radiat Res, 185(5), 473-84 .PMCID: PMC4893786.
203. Veiga LH, Lubin JH, Anderson H, et al. 2012. A pooled analysis of thyroid can-cer incidence following radiotherapy for childhood cancer. Radiat Res, 178(4), 365-376 .PMCID: PMC3488851.
204. Wagle N, Grabiner BC, Van Allen EM, et al. 2014. Response and acquired resistance to everolimus in anaplastic thyroid cancer. N Engl J Med, 371(15), 1426-1433 .PMCID: PMC4564868.
205. Wakeford R, Auvinen A, Gent RN, et al. 2016. Re: Thyroid cancer among young people in Fukushima. Epidemiology, 27(3), e20-21 .PMID: 26841059.
206. Wang JX, Zhang LA, Li BX, et al. 2002. Cancer incidence and risk estimation among medical x-ray workers in China, 1950-1995. Health Phys, 82(4), 455-466 .PMID: 11906134.
207. Ward MH, Kilfoy BA, Weyer PJ, et al. 2010. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology, 21(3), 389-395 .PMCID: PMC2879161.
208. Wells SA, Jr., Asa SL, Dralle H, et al. 2015. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid, 25(6), 567-610 .PMCID: PMC4490627.
209. Weng MY, Huang YT, Liu MF, and Lu TH. 2012. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan. Ann Rheum Dis, 71(4), 524-527 .PMID: 22072014.
210. Wiersinga WM. 2013. Smoking and thyroid. Clin Endocrinol (Oxf), 79(2), 145-151 .PMID: 23581474.
211. Williams D. 2002. Cancer after nuclear fallout: lessons from the Chernobyl accident. Nat Rev Cancer, 2(7), 543-549 .PMID: 12094241.
212. Williams D. 2015. Thyroid growth and cancer. Eur Thyroid J, 4(3), 164-173 .PMCID: PMC4637514.
213. Wolinski K, Czarnywojtek A, and Ruchala M. 2014. Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly: meta-analysis and systematic review. PLoS One, 9(2), e88787 .PMCID: PMC3925168.
214. Wong EY, Ray R, Gao DL, et al. 2006. Reproductive history, occupational exposures, and thyroid cancer risk among women textile workers in Shanghai, China. Int Arch Occup Environ Health, 79(3), 251-258 .PMID: 16220287.
215. World Health Organization. 1999. Guidelines for iodine prophylaxis following radiation accidents: update. Genevea: WHO.
216. Xiao Q, Park Y, Hollenbeck AR, and Kitahara CM. 2014. Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev, 23(6), 1102-1108 .PMCID: PMC4047159.
217. Xing M, Liu R, Liu X, et al. 2014. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol, 32(25), 2718-2726 .PMID: 25024077.
218. Xu L, Li G, Wei Q, El-Naggar AK, and Sturgis EM. 2012. Family history of cancer and risk of sporadic differentiated thyroid carcinoma. Cancer, 118(5), 1228-1235 .PMCID: PMC3208119.
219. Yamashita S. 2014. Tenth Warren K. Sinclair keynote address: the Fukushima nuclear power plant accident and comprehensive health risk management. Health Phys, 106(2), 166-180 .PMID: 24378490.
220. Yamashita S, and Radiation Medical Science Center for the Fukushima Health Management S. 2016. Comprehensive health risk management after the Fukushima nuclear power plant accident. Clin Oncol (R Coll Radiol), 28(4), 255-262 .PMID: 26817782.
221. Yu GP, Li JC, Branovan D, McCormick S, and Schantz SP. 2010. Thyroid cancer incidence and survival in the national cancer institute surveillance, epidemiology, and end results race/ethnicity groups. Thyroid, 20(5), 465-473 .PMID: 20384488.
222. Zablotska LB, Ron E, Rozhko AV, et al. 2011. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer, 104(1), 181-187 .PMCID: PMC3039791.
223. Zamora-Ros R, Rinaldi S, Biessy C, et al. 2015a. Reproductive and menstrual factors and risk of differentiated thyroid carcinoma: the EPIC study. Int J Cancer, 136(5), 1218-1227 .PMID: 25041790.
224. Zamora-Ros R, Rinaldi S, Tsilidis KK, et al. 2015b. Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study. Int J Cancer, 138(1), 65-73 .PMID: 26190646.
225. Zhang M, Li XM, Wang GS, et al. 2014. Thyroid cancer in systemic lupus erythematosus: a meta analysis. Int J Clin Exp Pathol, 7(9), 6270-6273 .PMCID: PMC4203250.
226. Zhu J, Zhu X, Tu C, et al. 2015. Parity and thyroid cancer risk: a meta-analysis of epidemiological studies. Cancer Med, 5(4), 739-752 .PMID: 26714593.
227. Zimmermann MB, and Galetti V. 2015. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res, 8, 8 .PMCID: PMC4490680.